Suppr超能文献

双氯芬酸加利多卡因凝胶用于宫内节育器放置术中的镇痛:一项随机、双盲、安慰剂对照研究

Diclofenac plus lidocaine gel for pain relief during intrauterine device insertion. A randomized, double-blinded, placebo-controlled study.

作者信息

Fouda Usama M, Salah Eldin Noha M, Elsetohy Khaled A, Tolba Hoda A, Shaban Mona M, Sobh Sherin M

机构信息

Department of Obstetrics and Gynecology, Faculty of medicine, Cairo University, Cairo, Egypt.

出版信息

Contraception. 2016 Jun;93(6):513-8. doi: 10.1016/j.contraception.2016.02.001. Epub 2016 Feb 4.

Abstract

OBJECTIVE

To determine the effectiveness of diclofenac potassium combined with 2% lidocaine gel in reducing the pain of intrauterine device (IUD) insertion.

STUDY DESIGN

We randomized 90 parous women requesting copper T380A IUD insertion in a 1:1 ratio to active or placebo treatment. Active treatment included administration of two 50-mg diclofenac potassium tablets 1h before IUD insertion, application of 3mL of 2% lidocaine gel on the anterior cervical lip 3min before IUD insertion and placement of a cotton swab soaked in 2% lidocaine gel in the cervical canal 3min before IUD insertion. Women in the placebo group received placebo tablets and gel. Participants assessed pain intensity using a 10-cm visual analog scale (VAS). We considered a 2-cm difference in VAS pain score between both groups during IUD insertion to be a clinically significant difference.

RESULTS

Subjects receiving active treatment, as compared to placebo, experienced less pain during tenaculum placement (1.66±0.85 vs. 2.33±1.19, p=.003) and IUD insertion (3.14±0.92 vs. 3.94±1.3, p=.001). Women who delivered only by cesarean section had higher pain scores with IUD insertion compared with women with previous vaginal deliveries (4.41±1.24 vs. 3.29±1.05, p=.001).

CONCLUSION

Diclofenac potassium combined with 2% lidocaine gel slightly reduced pain scores during tenaculum application and copper IUD insertion in parous women; however, the reduction in pain scores lacked clinical significance.

IMPLICATIONS

Although we found a statistically significant lowering of pain scores with pretreatment with diclofenac potassium and lidocaine gel in parous women having copper IUD placement, the reduction is not clinically relevant. These findings may be more relevant for nulliparous women who experience more pain than parous women with IUD insertion and support studies of diclofenac potassium and lidocaine gel in this population.

摘要

目的

确定双氯芬酸钾联合2%利多卡因凝胶在减轻宫内节育器(IUD)置入疼痛方面的有效性。

研究设计

我们将90名要求置入铜T380A宫内节育器的经产妇按1:1比例随机分为活性治疗组或安慰剂治疗组。活性治疗包括在IUD置入前1小时服用两片50毫克双氯芬酸钾片,在IUD置入前3分钟在宫颈前唇涂抹3毫升2%利多卡因凝胶,并在IUD置入前3分钟在宫颈管内放置一根浸泡在2%利多卡因凝胶中的棉拭子。安慰剂组的女性接受安慰剂片剂和凝胶。参与者使用10厘米视觉模拟量表(VAS)评估疼痛强度。我们认为IUD置入期间两组间VAS疼痛评分相差2厘米具有临床显著差异。

结果

与安慰剂组相比,接受活性治疗的受试者在宫颈钳放置期间(1.66±0.85对2.33±1.19,p = 0.003)和IUD置入期间(3.14±0.92对3.94±1.3,p = 0.001)疼痛较轻。仅通过剖宫产分娩的女性与既往有阴道分娩史的女性相比,IUD置入时疼痛评分更高(4.41±1.24对3.29±1.05,p = 0.001)。

结论

双氯芬酸钾联合2%利多卡因凝胶可使经产妇在宫颈钳应用和铜IUD置入期间的疼痛评分略有降低;然而,疼痛评分的降低缺乏临床意义。

启示

尽管我们发现经产妇在置入铜IUD前用双氯芬酸钾和利多卡因凝胶预处理后疼痛评分有统计学意义的降低,但这种降低在临床上并不相关。这些发现可能与未产妇更为相关,因为未产妇在IUD置入时比经产妇经历更多疼痛,并支持在该人群中对双氯芬酸钾和利多卡因凝胶进行研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验